Top 5 Stocks to Buy Now
→ Four winners over 400%. Here's #5 (From Golden Portfolio) (Ad)tc pixel
NASDAQ:GCTK

GlucoTrack Q2 2024 Earnings Report

GlucoTrack logo
$0.36 +0.00 (+0.14%)
Closing price 06/23/2026 04:00 PM Eastern
Extended Trading
$0.36 0.00 (-0.93%)
As of 06/23/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

GlucoTrack EPS Results

Actual EPS
-$984.00
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

GlucoTrack Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

GlucoTrack Announcement Details

Quarter
Q2 2024
Date
8/13/2024
Time
N/A
Conference Call Date
Tuesday, August 13, 2024
Conference Call Time
8:00AM ET

Conference Call Resources

Powered by Quartr

Earnings Documents

GlucoTrack's Q2 2024 Quarterly reportQuarterly report
(10-Q)

GlucoTrack Earnings Headlines

Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association’s 2026 Scientific Sessions
May 26, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/glucotrack-to-highlight-implantable-continuous-blood-glucose-monitoring-technology-at-the-american-diabetes-association-s-2026-scientific-sessions-1036193706
Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association's 2026 Scientific Sessions
May 26, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/26/3301032/0/en/glucotrack-to-highlight-implantable-continuous-blood-glucose-monitoring-technology-at-the-american-diabetes-association-s-2026-scientific-sessions.html
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel
 |  Porter & Company (Ad)
GlucoTrack, Inc.: Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
May 15, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-05/68505758-glucotrack-inc-glucotrack-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights-399.htm
Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
May 14, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/14/3295471/0/en/glucotrack-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights.html
GlucoTrack Inc.
May 13, 2026  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/gctk/financials
See More GlucoTrack Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GlucoTrack? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GlucoTrack and other key companies, straight to your email.

About GlucoTrack

GlucoTrack (NASDAQ:GCTK), a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

View GlucoTrack Profile
Earnings Tools